GHTF (Global Harmonisation Task Force) clinical evidence group sets clear agenda
This article was originally published in Clinica
Executive Summary
The inaugural meeting of the new study group 5 on clinical evidence set up within the Global Harmonisation Task Force agreed its agenda for the year at its meeting on January 17-18. Chaired by Graeme Harris, chief clinical adviser at the Office of Devices, Blood and Tissues, of Australia's Therapeutics Goods Administration, the members of the group reached a consensus on how to proceed and share out information gathering and document drafting roles.